[18F]-JNJ-64413739

· Janssen (Johnson & Johnson)

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for [18F]-JNJ-64413739, covering 2025-04-27 to 2025-04-27. Get the full timeline:

Most recent: Clinical Trial Update: A Positron Emission Tomography (PET) Study to Investigate P2X7 Receptor Occupancy by JNJ-55308942 Using [18F]-JNJ-64413739 [Phase 1]

See pricing